Page last updated: 2024-12-05

triethylenediamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Triethylenediamine, also known as 1,4-diazabicyclo[2.2.2]octane (DABCO), is a heterocyclic organic compound. It is a colorless solid with a melting point of 159-161 °C. DABCO is a strong base and a good nucleophile. It is used as a catalyst in a variety of organic reactions, such as the Diels-Alder reaction, the Michael reaction, and the Baylis-Hillman reaction. DABCO is also used as a polymerization catalyst and as a curing agent for epoxy resins. DABCO has been shown to have antifungal and antibacterial properties. DABCO is studied due to its wide range of applications, particularly in organic synthesis and material science. Its unique structural features, strong basicity, and nucleophilicity contribute to its versatility as a catalyst and reagent in various chemical processes. Research continues to explore its potential in diverse fields, including polymer chemistry, pharmaceutical chemistry, and agriculture.'

triethylenediamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

triethylenediamine : An organic heterobicylic compound that is piperazine with an ethane-1,2-diyl group forming a bridge between N1 and N4. It is typically used as a catalyst in polymerization reactions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9237
CHEMBL ID3183414
CHEBI ID151129
SCHEMBL ID14938
SCHEMBL ID7266053
MeSH IDM0050426

Synonyms (111)

Synonym
1,4-diazabicyclo-(2,2,2)-octane
gtpl2577
einecs 205-999-9
dabco r-8020
dabco crystal
1,4-diazobicyclo(2.2.2)octane
thancat td 33
1,4-diazabicyclo-octane
nsc 56362
bicyclo(2,2,2)-1,4-diazaoctane
ccris 6692
dabco s-25
dabco eg
teda
1,4-diazabicyclo(2.2.2)octane
ai3-24809
hsdb 5556
texacat td 100
1,4-diazobicyclo[2.2.2]octane
1,4-diaza[2.2.2]bicyclooctane
1,4-ethylenepiperazine
nsc56362
d 33lv
dabco 33lv
bicyclo[2.2.2]-1,4-diazaoctane
nsc-56362
n,n'-endo-ethylenepiperazine
280-57-9
TED ,
1,4-diazabicyclo[2.2.2]octane
triethylenediamine
inchi=1/c6h12n2/c1-2-8-5-3-7(1)4-6-8/h1-6h
dabco
dabco(r) 33-lv
1,4-diazabicyclo[2.2.2]octane, reagentplus(r), >=99%
D0134
1,4-diazabicyclo-[2.2.2]octane
CHEBI:151129
AKOS000119052
NCGC00249025-01
x8m57r0js5 ,
ec 205-999-9
unii-x8m57r0js5
1,4-diazabicyclo [2.2.2] octane
dtxsid0022016 ,
NCGC00256609-01
cas-280-57-9
tox21_302908
dtxcid902016
tox21_201323
NCGC00258875-01
1,4-diaza-bicyclo[2.2.2]octane
1,4-diazabicyclo[2,2,2]octane
triethylenediamine [hsdb]
triethylene diamine
1,4-diazabicyclo-2,2,2-octane
triethylenediamine [mi]
SCHEMBL14938
SCHEMBL7266053
BP-13441
1,4-diazabicyclo[2.2.2] octane
1,4-diazabicylo[2.2.2]octane
1,4-diazabicyclo (2.2.2)octane
1,4-diazabicyclo-[2.2.2]-octane
1,4-di azabicyclo[2.2.2]octane
1,4-diazabicyclo-[2,2,2]-octane
1,4- diazabicyclo(2,2,2)octane
1,4-diazabicyclo(2.2.2)-octane
1,4-diazabicyclo (2,2,2) octane
1,4-diazabicyclo (2.2.2) octane
1,4diazabicyclo[2,2,2]octane
1,4-diazobicyclo[2,2,2]octane
1,4-diazobicyclo(2,2,2)octane
1,4-diaza bicyclo[2.2.2]octane
1,4-diazabicyclo [2.2.2]octane
1,4 diazabicyclo[2,2,2]octane
1,4-diaza bicyclo-[2,2.2]-octane
1,4-diaza-bicyclo-[2,2,2]-octane
1,4-diazabicyclo(2.2.2) octane
1,4-diazabicyclo[2.2.21octane
1,4-diazabicyclo (2,2,2)octane
1,4-diazabicyclo[2.2.2]-octane
1,4-diaza bicyclo[2,2,2]octane
1,4-diazabicyclo-[2,2,2]octane
1,4-diazabicyclo[2,2,21octane
1.4-diazabicyclo[2.2.2]octan
1,4-diazabicyclo(2,2,2)octane
1,4-diazabicyclo[2,2,2]-octane
1,4-diazabicylco[2,2,2]octane
Q-201875
88935-43-7
tegoamin 33
teda-l33
texacat td-33
bicyclo[2.2.2]octane, 1,4-diaza-
dabco crystalline
CHEMBL3183414
mfcd00006689
F1908-0059
D70975
triethylene-diamine
1,4-diazabicyclo[2.2.2]octane, vetec(tm) reagent grade, 98%
1,4-diazabicyclo[2.2.2]octane (dabco)
FT-0700572
Q423673
CS-W020025
AMY25627
STL185594
PS-11951
EN300-18991
HY-Y0566

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" A low concentration of hyp (5 x 10(-9) M) was highly toxic to MRC5 cells, producing 15% survival for an irradiation period of 40 min."( Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5.
Favier, A; Hadjur, C; Jardon, P; Parat, MO; Richard, MJ, 1995
)
0.29
"The connection between the mode of toxic action and the genetic response caused by the type I photosensitizer and photosynthesis inhibitor neutral red (NR) and the type II photosensitizer rose bengal (RB) was investigated in the green alga Chlamydomonas reinhardtii."( Photosensitizers neutral red (type I) and rose bengal (type II) cause light-dependent toxicity in Chlamydomonas reinhardtii and induce the Gpxh gene via increased singlet oxygen formation.
Eggen, RL; Fischer, BB; Krieger-Liszkay, A, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
catalystA substance that increases the rate of a reaction without modifying the overall standard Gibbs energy change in the reaction.
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
saturated organic heterobicyclic parent
diamineAny polyamine that contains two amino groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency45.20850.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency1.42020.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency4.36470.000229.305416,493.5996AID743069
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency34.67700.154917.870243.6557AID1346891
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346705Rat Kv3.4 (Voltage-gated potassium channels)2006Molecular pharmacology, Mar, Volume: 69, Issue:3
1,4-Diazabicyclo[2.2.2]octane derivatives: a novel class of voltage-gated potassium channel blockers.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (182)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (17.58)18.7374
1990's15 (8.24)18.2507
2000's51 (28.02)29.6817
2010's66 (36.26)24.3611
2020's18 (9.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.77 (24.57)
Research Supply Index5.25 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index60.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.05%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other188 (98.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]